Skip to content

Dogwood Therapeutics DWTX Debt Conversion Accrued Interest On Debt Amount

Debt Conversion Accrued Interest On Debt Amount at other companies

Alpha Cognition logo
Alpha CognitionACOG
$16.5K
MRD
Meridian Holdings, Inc. MRDN
$0-100%
Gloo Holdings, Inc.
 logo
Gloo Holdings, Inc. GLOO
$22.54M
SB Financial Group logo
SB Financial GroupSBFG
3.7%0.0pp
QT Imaging Holdings, Inc. logo
QT Imaging Holdings, Inc.QTI
$0-100%
Horizon Technology Finance logo
Horizon Technology FinanceHRZN
$15.05M

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept dwtx:DebtConversionAccruedInterestOnDebtAmount.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's debt conversion accrued interest on debt amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's debt conversion accrued interest on debt amount?
Dogwood Therapeutics (DWTX) reported debt conversion accrued interest on debt amount of $426.89K in Q1 2025.
What does debt conversion accrued interest on debt amount mean?
Represents the portion of accrued interest on debt obligations that is settled through the conversion of debt into equity instruments rather than through cash payments. This metric highlights the company's strategy to manage interest liabilities and preserve cash reserves by leveraging equity-based settlements. It is a key indicator of non-cash financing activities and capital structure adjustments.